Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
530
datasets available to search
ShareScore release 0.9.0
Dataset results
530 results for “Hip fracture”
Thromboelastography (TEG) and Clopidogrel Withdrawal Time in Elderly Patients With Hip Fracture
ClinicalTrials.gov study NCT04165538. IPD Sharing: YES. Countries: 0. Publications: 0.
Tranexamic Acid in Hip Fracture Surgery
ClinicalTrials.gov study NCT02736383. IPD Sharing: NO. Countries: 0. Publications: 0.
Early Administration Of Tranexamic Acid And Acute Blood Loss In Patients With Hip Fractures
ClinicalTrials.gov study NCT05518279. IPD Sharing: NO. Countries: 0. Publications: 0.
Pericapsular Nerve Block Versus Propofol During Hip Fractures Surgery
ClinicalTrials.gov study NCT06631118. IPD Sharing: YES. Countries: 0. Publications: 0.
Low- vs. Normal-Flow Anesthesia and Delirium After Hip Fracture in the Elderly
ClinicalTrials.gov study NCT06973967. IPD Sharing: NO. Countries: 0. Publications: 0.
Locking Compression Plate Fixation Versus Revision- Prosthesis of Vancouver-B2, B3 and C Periprosthetic Femoral Fractures After Total Hip Replacement
ClinicalTrials.gov study NCT02391129. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Hip-Fracture Surgery on Patients in Clopidogrel Therapy
ClinicalTrials.gov study NCT02391883. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Evaluation of Health and Social Interventions Aimed to Old People Discharged From Hospital After a Hip or Wrist Fracture Due to a Fall
ClinicalTrials.gov study NCT02802358. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Dataset related to article: "Functional recovery in hip fracture patients: the role of pharmacotherapy"
<p>We provide the raw data used for the following article:</p> <ul> <li>Gialanella B, Santoro R, Prometti P, Giordano A, Monguzzi V, Comini L, Olivares A, Grioni G.<br> <em>Functional recovery in hip fracture patients: the role of pharmacotherapy</em>.<br> "Aging Clin Exp Res." 2020 Jan;32(1):49-57.<br> doi: 10.1007/s40520-019-01175-w. Epub 2019 Mar 21. PMID: 30900212.</li> </ul> <p><strong>Background and aim: </strong>The aim of this prospective observational cohort study was to verify the relationship between number of drugs used and functional outcome in hip fracture patients undergoing rehabilitation.</p> <p><strong>Methods: </strong>This study was conducted on 139 patients with hip fracture who underwent a rehabilitation program. Efficiency rate in the Functional Independence Measure (FIM) and Berg Balance Scale (BBS), and length of stay (LOS) were the outcome measures.</p> <p><strong>Results: </strong>At the end of rehabilitation, 66.1% of patients showed an increase in number of drugs used, while 33.9% used the same or lower number of drugs than at admission. At the end of rehabilitation patients with increased pharmacotherapy took a higher total number of drug classes (p = 0.001), had longer LOS (p = 0.009) and lower Berg efficiency (p = 0.048) than patients with the same or lower pharmacotherapy. The number of drugs used at discharge was an independent determinant of LOS (beta = 0.19, p = 0.022) and FIM efficiency (beta = - 0.20, p = 0.025). Age was a determinant of LOS (beta = 0.17, p = 0.044) and BBS efficiency (beta = - 0.23, p = 0.009), while CIRS severity was a determinant of BBS efficiency only (beta = - 0.22, p = 0.016).</p> <p><strong>Discussion: </strong>Findings of study indicate that in hip fracture patients, the number of drugs prescribed at discharge is an important indicator of LOS and rehabilitation efficiency.</p> <p><strong>Conclusions: </strong>These findings can help the physician to better plan the rehabilitation of hip fracture patients who require polypharmacy.</p>
Data from: Health-related quality of life and associated factors after hip fracture. Results from a six-month prospective cohort study
<p>This is the raw data and R code from the paper "Health-related quality of life and associated factors after hip fracture. Results from a six-month prospective cohort study" (project EMAAge).</p> <p><strong>Background.</strong> Hip fractures are a major public health problem with increasing relevance in aging societies. They are associated with high mortality rates, morbidity, and loss of independence. The aim of the EMAAge study was to determine the impact of hip fractures on patient-reported health-related quality of life (HRQOL), and to identify potential risk factors for worse outcomes. </p> <p><strong>Methods.</strong> EMAAge is a multicenter, prospective cohort study of patients who suffered a hip fracture. Patients or, if necessary, proxies were interviewed after initial treatment and after six months using standardized questionnaires including the EQ-5D-5L instrument, the Oxford Hip Score, the PHQ-4, the Short Nutritional Assessment Questionnaire, and items on patients’ living situation. Medical data on diagnoses, comorbidities, medications, and hospital care were derived from hospital information systems. </p> <p><strong>Results. </strong>A total of 326 patients were included. EQ-5D index values decreased from a mean of 0.70 at baseline to 0.63 at six months. The mean self-rated health on the EQ-VAS decreased from 69.9 to 59.4. Multivariable linear regression models revealed three relevant associated factors with the six-months EQ-5D index: symptoms of depression and anxiety, pre-fracture limitations in activities of daily living, and no referral to a rehabilitation facility had a negative impact. In addition, the six-months EQ-VAS was negatively associated with polypharmacy, living in a facility, and migration background. </p> <p><strong>Conclusions. </strong>Hip fractures have a substantial negative impact on patients’ HRQOL. Our results suggest that there are modifying factors that need further investigation including polypharmacy and migration background. Structured and timely rehabilitation seems to be a protective factor.</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.